(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:735774 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATP1B1 mRNA CTD PMID:22079256 (R)-lipoic acid multiple interactions ISO RGD:731614 6480464 Thioctic Acid affects the reaction [Dietary Fats affects the expression of ATP1B1 mRNA] CTD PMID:27260466 1,2-dimethylhydrazine decreases expression ISO RGD:731614 6480464 1, 2-Dimethylhydrazine results in decreased expression of ATP1B1 mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO RGD:731614 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP1B1 mRNA CTD PMID:22206623 1-(5-isoquinolinesulfonyl)-2-methylpiperazine decreases expression EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine results in decreased expression of ATP1B1 mRNA CTD PMID:11204457 1-(5-isoquinolinesulfonyl)-2-methylpiperazine multiple interactions EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Ouabain results in increased expression of ATP1B1 mRNA] CTD PMID:11204457 17beta-estradiol multiple interactions ISO RGD:735774 6480464 EGF protein inhibits the reaction [Estradiol results in decreased expression of ATP1B1 mRNA] CTD PMID:24758408 17beta-estradiol increases expression ISO RGD:735774 6480464 Estradiol results in increased expression of ATP1B1 mRNA CTD PMID:31614463 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ATP1B1 mRNA CTD PMID:32145629 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of ATP1B1 mRNA CTD PMID:26496021 17beta-estradiol decreases expression ISO RGD:735774 6480464 Estradiol results in decreased expression of ATP1B1 mRNA CTD PMID:16474171 , PMID:24758408 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:731614 6480464 2 more ... CTD PMID:32352317 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731614 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of ATP1B1 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ATP1B1 gene] CTD PMID:16214954 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP1B1 mRNA CTD PMID:32277265 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP1B1 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:731614 6480464 Tetrachlorodibenzodioxin affects the expression of ATP1B1 mRNA CTD PMID:21570461 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ATP1B1 mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:731614 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP1B1 mRNA CTD PMID:18691609 more ... 2-butoxyethanol decreases expression ISO RGD:731614 6480464 n-butoxyethanol results in decreased expression of ATP1B1 mRNA CTD PMID:19812364 2-methylcholine affects expression ISO RGD:735774 6480464 beta-methylcholine affects the expression of ATP1B1 mRNA CTD PMID:21179406 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine increases expression EXP 6480464 Puromycin Aminonucleoside results in increased expression of ATP1B1 mRNA CTD PMID:11675400 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of ATP1B1 mRNA CTD PMID:28522335 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of ATP1B1 mRNA CTD PMID:19162173 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP1B1 mRNA CTD PMID:36041667 4-hydroxyphenyl retinamide increases expression ISO RGD:731614 6480464 Fenretinide results in increased expression of ATP1B1 mRNA CTD PMID:28973697 5-(2-methylpiperazine-1-sulfonyl)isoquinoline decreases expression EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine results in decreased expression of ATP1B1 mRNA CTD PMID:11204457 5-(2-methylpiperazine-1-sulfonyl)isoquinoline multiple interactions EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Ouabain results in increased expression of ATP1B1 mRNA] CTD PMID:11204457 5-aza-2'-deoxycytidine multiple interactions ISO RGD:735774 6480464 [Decitabine co-treated with Vorinostat] affects the expression of ATP1B1 mRNA more ... CTD PMID:17330099 , PMID:24452105 9-cis-retinoic acid decreases expression EXP 6480464 Alitretinoin results in decreased expression of ATP1B1 mRNA CTD PMID:16648578 acetamide increases expression EXP 6480464 acetamide results in increased expression of ATP1B1 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ATP1B1 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO RGD:731614 6480464 Aflatoxin B1 results in decreased expression of ATP1B1 mRNA CTD PMID:19770486 aflatoxin B1 decreases methylation ISO RGD:735774 6480464 Aflatoxin B1 results in decreased methylation of ATP1B1 gene CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:735774 6480464 Tretinoin results in decreased expression of ATP1B1 mRNA CTD PMID:33167477 amiodarone decreases expression EXP 6480464 Amiodarone results in decreased expression of ATP1B1 protein CTD PMID:8071999 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ATP1B1 mRNA CTD PMID:16483693 Aroclor 1254 decreases expression ISO RGD:731614 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ATP1B1 mRNA CTD PMID:23650126 arsenous acid decreases expression ISO RGD:735774 6480464 Arsenic Trioxide results in decreased expression of ATP1B1 mRNA, Arsenic Trioxide results in decreased expression of ATP1B1 protein CTD PMID:15761015 , PMID:25419056 arsenous acid decreases response to substance ISO RGD:735774 6480464 ATP1B1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 astemizole increases expression EXP 6480464 Astemizole results in increased expression of ATP1B1 mRNA CTD PMID:20221588 atrazine increases expression ISO RGD:735774 6480464 Atrazine results in increased expression of ATP1B1 mRNA CTD PMID:22378314 atrazine multiple interactions ISO RGD:731614 6480464 Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP1B1 mRNA] CTD PMID:27112537 atrazine decreases expression ISO RGD:731614 6480464 Atrazine results in decreased expression of ATP1B1 mRNA CTD PMID:27112537 benzo[a]pyrene decreases expression ISO RGD:731614 6480464 Benzo(a)pyrene results in decreased expression of ATP1B1 mRNA CTD PMID:22228805 , PMID:23735875 benzo[a]pyrene increases expression ISO RGD:735774 6480464 Benzo(a)pyrene results in increased expression of ATP1B1 mRNA CTD PMID:31255691 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:735774 6480464 7 more ... CTD PMID:20018196 bexarotene decreases expression EXP 6480464 bexarotene results in decreased expression of ATP1B1 mRNA CTD PMID:16648578 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP1B1 mRNA, [bisphenol A co-treated with Estradiol] results in increased expression of ATP1B1 mRNA CTD PMID:26496021 , PMID:36041667 bisphenol A increases expression ISO RGD:731614 6480464 bisphenol A results in increased expression of ATP1B1 mRNA CTD PMID:32156529 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ATP1B1 mRNA CTD PMID:32145629 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ATP1B1 mRNA CTD PMID:30816183 more ... bisphenol A affects expression ISO RGD:735774 6480464 bisphenol A affects the expression of ATP1B1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:735774 6480464 bisphenol A results in decreased expression of ATP1B1 mRNA CTD PMID:16474171 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATP1B1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:731614 6480464 bisphenol A results in decreased expression of ATP1B1 mRNA CTD PMID:26063408 , PMID:26512966 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP1B1 mRNA CTD PMID:36041667 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of ATP1B1 mRNA CTD PMID:32479839 butanal decreases expression ISO RGD:735774 6480464 butyraldehyde results in decreased expression of ATP1B1 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO RGD:735774 6480464 Cadmium Chloride results in decreased expression of ATP1B1 mRNA CTD PMID:33770205 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of ATP1B1 mRNA CTD PMID:17293106 calcitriol decreases expression ISO RGD:735774 6480464 Calcitriol results in decreased expression of ATP1B1 mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:735774 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ATP1B1 mRNA CTD PMID:21592394 calcium atom multiple interactions EXP 6480464 Calcium affects the reaction [Ouabain results in increased expression of ATP1B1 mRNA] CTD PMID:11204457 calcium(0) multiple interactions EXP 6480464 Calcium affects the reaction [Ouabain results in increased expression of ATP1B1 mRNA] CTD PMID:11204457 carbamazepine affects expression ISO RGD:735774 6480464 Carbamazepine affects the expression of ATP1B1 mRNA CTD PMID:25979313 carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon affects the expression of ATP1B1 mRNA CTD PMID:19836432 carbon nanotube decreases expression ISO RGD:731614 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:735774 6480464 CGP 52608 promotes the reaction [RORA protein binds to ATP1B1 gene] CTD PMID:28238834 chloroprene increases expression ISO RGD:731614 6480464 Chloroprene results in increased expression of ATP1B1 mRNA CTD PMID:23125180 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of ATP1B1 mRNA CTD PMID:23125180 choline multiple interactions ISO RGD:731614 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATP1B1 gene CTD PMID:20938992 chromium(6+) affects expression ISO RGD:731614 6480464 chromium hexavalent ion affects the expression of ATP1B1 mRNA CTD PMID:28472532 chromium(6+) affects expression ISO RGD:735774 6480464 chromium hexavalent ion affects the expression of ATP1B1 mRNA CTD PMID:30690063 ciglitazone decreases expression EXP 6480464 ciglitazone results in decreased expression of ATP1B1 mRNA CTD PMID:22193206 cisplatin multiple interactions ISO RGD:735774 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ATP1B1 mRNA] CTD PMID:21858171 clofibrate decreases expression ISO RGD:731614 6480464 Clofibrate results in decreased expression of ATP1B1 mRNA CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP1B1 mRNA CTD PMID:17602206 cobalt dichloride increases expression ISO RGD:735774 6480464 cobaltous chloride results in increased expression of ATP1B1 mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:731614 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATP1B1 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:731614 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ATP1B1 mRNA CTD PMID:15467011 coumestrol multiple interactions ISO RGD:735774 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP1B1 mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:731614 6480464 Asbestos, Crocidolite results in decreased expression of ATP1B1 mRNA CTD PMID:29279043 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of ATP1B1 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO RGD:731614 6480464 Cyclosporine results in decreased expression of ATP1B1 mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:735774 6480464 Cyclosporine results in decreased expression of ATP1B1 mRNA CTD PMID:22147139 more ... cytarabine decreases expression ISO RGD:735774 6480464 Cytarabine results in decreased expression of ATP1B1 mRNA CTD PMID:21198554 dextran sulfate multiple interactions ISO RGD:731614 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP1B1 mRNA CTD PMID:29950665 diarsenic trioxide decreases expression ISO RGD:735774 6480464 Arsenic Trioxide results in decreased expression of ATP1B1 mRNA, Arsenic Trioxide results in decreased expression of ATP1B1 protein CTD PMID:15761015 , PMID:25419056 diarsenic trioxide decreases response to substance ISO RGD:735774 6480464 ATP1B1 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:20707922 dibenzo[a,l]pyrene increases expression ISO RGD:735774 6480464 dibenzo(a, l)pyrene results in increased expression of ATP1B1 mRNA CTD PMID:31255691 dibutyl phthalate increases expression ISO RGD:731614 6480464 Dibutyl Phthalate results in increased expression of ATP1B1 mRNA CTD PMID:21266533 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ATP1B1 mRNA CTD PMID:21266533 diethylstilbestrol decreases expression ISO RGD:731614 6480464 Diethylstilbestrol results in decreased expression of ATP1B1 mRNA CTD PMID:17394237 diethylstilbestrol increases expression ISO RGD:735774 6480464 Diethylstilbestrol results in increased expression of ATP1B1 mRNA CTD PMID:36621641 dimethyl sulfoxide increases expression EXP 6480464 Dimethyl Sulfoxide results in increased expression of ATP1B1 mRNA CTD PMID:22193206 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of ATP1B1 mRNA, Oxygen results in increased expression of ATP1B1 mRNA CTD PMID:11713096 , PMID:22911455 diuron decreases expression EXP 6480464 Diuron results in decreased expression of ATP1B1 mRNA CTD PMID:21551480 diuron decreases expression ISO RGD:735774 6480464 Diuron results in decreased expression of ATP1B1 mRNA CTD PMID:35967413 dorsomorphin multiple interactions ISO RGD:735774 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP1B1 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:735774 6480464 Doxorubicin results in decreased expression of ATP1B1 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ATP1B1 mRNA CTD PMID:29391264 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of ATP1B1 mRNA, Endosulfan results in increased expression of ATP1B1 protein CTD PMID:31464424 Enterolactone multiple interactions ISO RGD:735774 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of ATP1B1 mRNA CTD PMID:19167446 ethanol multiple interactions ISO RGD:735774 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ATP1B1 mRNA CTD PMID:29432896 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ATP1B1 mRNA CTD PMID:24136188 , PMID:24793618 folic acid multiple interactions ISO RGD:731614 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:731614 6480464 Folic Acid results in decreased expression of ATP1B1 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:735774 6480464 Formaldehyde results in increased expression of ATP1B1 mRNA CTD PMID:23649840 fructose decreases expression EXP 6480464 Fructose results in decreased expression of ATP1B1 protein CTD PMID:26930160 furan increases methylation EXP 6480464 furan results in increased methylation of ATP1B1 gene CTD PMID:22079235 genistein decreases expression ISO RGD:735774 6480464 Genistein results in decreased expression of ATP1B1 mRNA CTD PMID:16474171 genistein increases expression EXP 6480464 Genistein results in increased expression of ATP1B1 mRNA CTD PMID:21782745 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of ATP1B1 mRNA CTD PMID:21782745 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of ATP1B1 mRNA CTD PMID:24136188 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of ATP1B1 mRNA CTD PMID:20621112 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of ATP1B1 mRNA CTD PMID:15860345 heparin multiple interactions EXP 6480464 Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ATP1B1 mRNA] CTD PMID:16401727 inulin multiple interactions ISO RGD:731614 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ATP1B1 mRNA CTD PMID:36331819 isoflavones increases expression ISO RGD:735774 6480464 Isoflavones results in increased expression of ATP1B1 mRNA CTD PMID:17374662 isoniazide increases expression ISO RGD:735774 6480464 Isoniazid results in increased expression of ATP1B1 mRNA CTD PMID:30008028 ivermectin decreases expression ISO RGD:735774 6480464 Ivermectin results in decreased expression of ATP1B1 protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:731614 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ATP1B1 gene CTD PMID:20938992 lead(0) affects expression ISO RGD:735774 6480464 Lead affects the expression of ATP1B1 mRNA CTD PMID:28903495 lipoic acid multiple interactions ISO RGD:731614 6480464 Thioctic Acid affects the reaction [Dietary Fats affects the expression of ATP1B1 mRNA] CTD PMID:27260466 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of ATP1B1 mRNA CTD PMID:16415329 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ATP1B1 mRNA more ... CTD PMID:16401727 , PMID:16415329 lycopene multiple interactions ISO RGD:731614 6480464 Lycopene inhibits the reaction [Atrazine results in decreased expression of ATP1B1 mRNA] CTD PMID:27112537 methoxychlor increases expression EXP 6480464 Methoxychlor results in increased expression of ATP1B1 mRNA CTD PMID:21782745 methoxychlor affects methylation EXP 6480464 Methoxychlor affects the methylation of ATP1B1 gene CTD PMID:35440735 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in increased expression of ATP1B1 mRNA CTD PMID:21782745 methylisothiazolinone increases expression ISO RGD:735774 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of ATP1B1 mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:735774 6480464 methylmercuric chloride results in increased expression of ATP1B1 mRNA CTD PMID:28001369 mirex decreases expression EXP 6480464 Mirex results in decreased expression of ATP1B1 mRNA CTD PMID:23153324 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ATP1B1 mRNA CTD PMID:17602206 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ATP1B1 mRNA CTD PMID:19638242 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ATP1B1 mRNA more ... CTD PMID:16401727 , PMID:16415329 nickel atom decreases expression ISO RGD:735774 6480464 Nickel results in decreased expression of ATP1B1 mRNA CTD PMID:25583101 nickel sulfate decreases expression ISO RGD:731614 6480464 nickel sulfate results in decreased expression of ATP1B1 mRNA CTD PMID:16100012 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of ATP1B1 mRNA CTD PMID:24136188 ochratoxin A decreases expression ISO RGD:735774 6480464 ochratoxin A results in decreased expression of ATP1B1 mRNA CTD PMID:30008028 ouabain multiple interactions EXP 6480464 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [Ouabain results in increased expression of ATP1B1 mRNA] more ... CTD PMID:11204457 ouabain increases expression EXP 6480464 Ouabain results in increased expression of ATP1B1 mRNA CTD PMID:11204457 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of ATP1B1 mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ATP1B1 mRNA CTD PMID:25729387 oxycodone increases expression EXP 6480464 Oxycodone results in increased expression of ATP1B1 mRNA CTD PMID:23439660 ozone increases expression EXP 6480464 Ozone results in increased expression of ATP1B1 mRNA CTD PMID:35737395 paracetamol affects expression ISO RGD:731614 6480464 Acetaminophen affects the expression of ATP1B1 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ATP1B1 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:735774 6480464 Acetaminophen affects the expression of ATP1B1 mRNA CTD PMID:25458485 paracetamol increases expression ISO RGD:735774 6480464 Acetaminophen results in increased expression of ATP1B1 mRNA CTD PMID:26690555 paracetamol decreases expression ISO RGD:735774 6480464 Acetaminophen results in decreased expression of ATP1B1 mRNA CTD PMID:21420995 , PMID:30008028 paraquat affects expression EXP 6480464 Paraquat affects the expression of ATP1B1 mRNA CTD PMID:16854511 paraquat increases expression EXP 6480464 Paraquat results in increased expression of ATP1B1 mRNA CTD PMID:16555045 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:21673325 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:731614 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ATP1B1 mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:735774 6480464 perfluorooctanoic acid results in decreased expression of ATP1B1 protein CTD PMID:26879310 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of ATP1B1 mRNA CTD PMID:19162173 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of ATP1B1 mRNA CTD PMID:11204457 phenylmercury acetate increases expression ISO RGD:735774 6480464 Phenylmercuric Acetate results in increased expression of ATP1B1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:735774 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP1B1 mRNA CTD PMID:27188386 phorbol 13-acetate 12-myristate increases expression EXP 6480464 Tetradecanoylphorbol Acetate results in increased expression of ATP1B1 mRNA CTD PMID:11204457 picoxystrobin decreases expression ISO RGD:735774 6480464 picoxystrobin results in decreased expression of ATP1B1 mRNA CTD PMID:33512557 pirinixic acid increases expression ISO RGD:731614 6480464 pirinixic acid results in increased expression of ATP1B1 mRNA CTD PMID:18445702 pirinixic acid decreases expression ISO RGD:731614 6480464 pirinixic acid results in decreased expression of ATP1B1 mRNA CTD PMID:23811191 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ATP1B1 mRNA CTD PMID:19162173 piroxicam decreases expression ISO RGD:735774 6480464 Piroxicam results in decreased expression of ATP1B1 mRNA CTD PMID:21858171 piroxicam multiple interactions ISO RGD:735774 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of ATP1B1 mRNA] CTD PMID:21858171 potassium bromate decreases expression ISO RGD:735774 6480464 potassium bromate results in decreased expression of ATP1B1 mRNA CTD PMID:30008028 potassium chromate multiple interactions ISO RGD:735774 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of ATP1B1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:735774 6480464 potassium chromate(VI) results in decreased expression of ATP1B1 mRNA CTD PMID:22079256 , PMID:22714537 potassium dichromate increases expression ISO RGD:735774 6480464 Potassium Dichromate results in increased expression of ATP1B1 mRNA CTD PMID:11678601 potassium dichromate decreases expression ISO RGD:731614 6480464 Potassium Dichromate results in decreased expression of ATP1B1 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of ATP1B1 mRNA CTD PMID:19162173 progesterone decreases expression ISO RGD:735774 6480464 Progesterone results in decreased expression of ATP1B1 mRNA CTD PMID:21540246 pyrogallol increases expression ISO RGD:731614 6480464 Pyrogallol results in increased expression of ATP1B1 mRNA CTD PMID:20362636 quartz affects expression EXP 6480464 Quartz affects the expression of ATP1B1 mRNA CTD PMID:19836432 quercetin multiple interactions ISO RGD:731614 6480464 Quercetin affects the reaction [Dietary Fats affects the expression of ATP1B1 mRNA] CTD PMID:27260466 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ATP1B1 mRNA more ... CTD PMID:16401727 , PMID:16415329 resveratrol decreases expression ISO RGD:731614 6480464 resveratrol results in decreased expression of ATP1B1 mRNA CTD PMID:22610192 resveratrol multiple interactions ISO RGD:731614 6480464 resveratrol affects the reaction [Dietary Fats affects the expression of ATP1B1 mRNA] CTD PMID:27260466 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ATP1B1 mRNA CTD PMID:28374803 sarin decreases expression ISO RGD:735774 6480464 Sarin results in decreased expression of ATP1B1 mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:735774 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ATP1B1 mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:735774 6480464 Silicon Dioxide analog results in decreased expression of ATP1B1 mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of ATP1B1 mRNA CTD PMID:22431001 silicon dioxide increases expression ISO RGD:735774 6480464 Silicon Dioxide analog results in increased expression of ATP1B1 mRNA CTD PMID:23806026 sodium dichromate decreases expression ISO RGD:731614 6480464 sodium bichromate results in decreased expression of ATP1B1 mRNA CTD PMID:31558096 succimer multiple interactions ISO RGD:731614 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATP1B1 mRNA CTD PMID:26378955 tacedinaline increases expression ISO RGD:735774 6480464 tacedinaline results in increased expression of ATP1B1 mRNA CTD PMID:33770205 tacrolimus hydrate decreases expression ISO RGD:731614 6480464 Tacrolimus results in decreased expression of ATP1B1 mRNA CTD PMID:25270620 tamoxifen affects expression ISO RGD:731614 6480464 Tamoxifen affects the expression of ATP1B1 mRNA CTD PMID:20937368 tebufenpyrad decreases expression ISO RGD:735774 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of ATP1B1 mRNA CTD PMID:33512557 testosterone decreases expression ISO RGD:735774 6480464 Testosterone results in decreased expression of ATP1B1 mRNA CTD PMID:21592394 testosterone multiple interactions ISO RGD:735774 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of ATP1B1 mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO RGD:731614 6480464 Carbon Tetrachloride results in increased expression of ATP1B1 mRNA CTD PMID:17484886 thapsigargin increases expression ISO RGD:735774 6480464 Thapsigargin results in increased expression of ATP1B1 mRNA CTD PMID:33770205 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ATP1B1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:731614 6480464 titanium dioxide results in decreased expression of ATP1B1 mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO RGD:731614 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of ATP1B1 mRNA CTD PMID:29950665 titanium dioxide increases expression ISO RGD:731614 6480464 titanium dioxide results in increased expression of ATP1B1 mRNA CTD PMID:27760801 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of ATP1B1 mRNA CTD PMID:25729387 topotecan increases expression EXP 6480464 Topotecan results in increased expression of ATP1B1 mRNA CTD PMID:25729387 trichloroethene increases expression ISO RGD:731614 6480464 Trichloroethylene results in increased expression of ATP1B1 mRNA CTD PMID:28973375 valproic acid increases methylation ISO RGD:735774 6480464 Valproic Acid results in increased methylation of ATP1B1 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:735774 6480464 Valproic Acid results in increased expression of ATP1B1 mRNA CTD PMID:28001369 , PMID:30008028 valproic acid affects expression ISO RGD:735774 6480464 Valproic Acid affects the expression of ATP1B1 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ATP1B1 mRNA CTD PMID:23034163 vorinostat multiple interactions ISO RGD:735774 6480464 [decitabine co-treated with vorinostat] affects the expression of ATP1B1 mRNA CTD PMID:17330099